Nayra Suélen Gomes Dias

Mrs. Nayra Suélen Gomes Dias

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in International Journal for Parasitology: Drugs and Drug Resistance
Verified
Journal Article
Open access
VRVanessa Ribeiro
Vanessa Ribeiro
NDNayra Suélen Gomes Dias
Nayra Suélen Gomes Dias
TPTaís Paiva
Taís Paiva
LHLuciana Hagstrom Hagström
Luciana Hagstrom Hagström
NNNadjar Nitz Nitz
Nadjar Nitz Nitz
MHMariana Hecht
Mariana Hecht
Chagas disease (CD) is a tropical neglected illness, affecting mainly populations of low socioeconomic status in Latin America. An estimated 6 to 8 million people worldwide are infected with Trypanosoma cruzi, the etiological agent of CD. Despite being one of the main global health problems, this disease continues without effective treatment during the chronic phase of the infection. The limitation of therapeutic strategies has been one of the biggest challenges on the fight against CD. Nifurtimox and benznidazole, developed in the 1970s, are still the only commercial options with established efficacy on CD. However, the efficacy of these drugs have a proven efficacy only during early infection and the benefits in the chronic phase are questionable. Consequently, there is a growing need for new pharmacological alternatives, either by optimization of existing drugs or by the formulation of new compounds. In the present study, a literature review of the currently adopted therapy, its concomitant combination with other drugs, and potential future treatments for CD was performed, considering articles published from 2012. The revised articles were selected according to the protocol of treatment: evaluation of drug association, drug repositioning and research of new drugs. As a result of the present revision, it was possible to conclude that the use of benznidazole in combination with other compounds showed better results when compared with its use as a single therapy. The search of new drugs has been the strategy most used in pursuing more effective forms of treatment for CD. However, studies have still focused on basic research, that is, they are still in a pre-clinical stage, using methodologies based on in vitro or in animal studies.

21 August 2019 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
MWMoisés Wesley
Moisés Wesley
AMAline Moraes
Aline Moraes
ARAna de Cássia Rosa
Ana de Cássia Rosa
JCJuliana Carvalho
Juliana Carvalho
TSTatiana Shiroma
Tatiana Shiroma
MHMariana Hecht
Mariana Hecht
Chagas disease (CD), caused by the protozoan Trypanosoma cruzi (T. cruzi), is the main parasitic disease in the Western Hemisphere. Unfortunately, its physiopathology is not completely understood, and cardiomegaly development is hard to predict. Trying to explain tissue lesion and the fact that only a percentage of the infected individuals develops clinical manifestations, a variety of mechanisms have been suggested as the provokers of CD, such as parasite persistence and autoimmune responses. However, holistic analysis of how parasite and host-related elements may connect to each other and influence clinical outcome is still scarce in the literature. Here, we investigated murine models of CD caused by three different pathogen strains: Colombian, CL Brener and Y strains, and employed parasitological and immunological tests to determine parasite load, antibody reactivity, and cytokine production during the acute and chronic phases of the disease. Also, we developed a quantitative PCR (qPCR) protocol to quantify T. cruzi kDNA minicircle integration into the mammalian host genome. Finally, we used a correlation analysis to interconnect parasite- and host-related factors over time. Higher parasite load in the heart and in the intestine was significantly associated with IgG raised against host cardiac proteins. Also, increased heart and bone marrow parasitism was associated with a more intense leukocyte infiltration. kDNA integration rates correlated to the levels of IgG antibodies reactive to host cardiac proteins and interferon production, both influencing tissue inflammation. In conclusion, our results shed light into how inflammatory process associates with parasite load, kDNA transfer to the host, autoreactive autoantibody production and cytokine profile. Altogether, our data support the proposal of an updated integrative theory regarding CD pathophysiology.

1 December 2019 in Microbial Pathogenesis
Verified
Journal Article
Closed access
ITIsabella Márcia Soares Nogueira Teotônio
Isabella Márcia Soares Nogueira Teotônio
NDNayra Suélen Gomes Dias
Nayra Suélen Gomes Dias
LHLuciana Hagström-Bex
Luciana Hagström-Bex
NNNadjar Nitz
Nadjar Nitz
Amanda Fortes FranciscoAmanda Fortes Francisco
Amanda Fortes Francisco
MHMariana Hecht
Mariana Hecht

1 January 2019 in Revista da Sociedade Brasileira de Medicina Tropical
Verified
Journal Article
Open access
PDF file
NDNayra Suélen Gomes Dias
Nayra Suélen Gomes Dias
BCBruna de Carvalho
Bruna de Carvalho
NNNadjar Nitz
Nadjar Nitz
LHLuciana Hagstrom Hagström
Luciana Hagstrom Hagström
TVTamires Vital
Tamires Vital
TVTamires Vital
Tamires Vital
Keywords: Congenital Chagas disease; Publications; Negligence

15 November 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
NDNayra Suélen Gomes Dias
Nayra Suélen Gomes Dias
MMMarina Dias Marques
Marina Dias Marques
ARAndressa Ribeiro
Andressa Ribeiro
NJNelio Moura Junior
Nelio Moura Junior
AMAline Moraes
Aline Moraes
MHMariana Hecht
Mariana Hecht
Chagas disease (CD), a disease affecting millions globally, remains shrouded in scientific uncertainty, particularly regarding the role of the intestinal microbiota in disease progression. This study investigates the effects of antibiotic-induced microbiota depletion on parasite burden, immune responses, and clinical outcomes in BALB/c mice infected with either the Trypanosoma cruzi Colombiana or CL Brener strains. Mice were treated with a broad-spectrum antibiotic cocktail before infection, and parasite burden was quantified via qPCR at 30 and 100 days post-infection (dpi). Immune responses were analyzed using flow cytometry and ELISA, while histopathology was conducted on cardiac and intestinal tissues. Antibiotic treatment uncovered strain-specific correlations, with Colombiana infections affecting Bifidobacterium populations and CL Brener infections linked to Lactobacillus. Microbiota depletion initially reduced parasite burden in the heart and intestine, but an increase was observed in the chronic phase, except in the CL Brener-infected gut, where an early burden spike was followed by a decline. Antibiotic-induced bacterial shifts, such as reductions in Bacteroides and Bifidobacterium, promoted a more pro-inflammatory immune profile. These findings highlight the importance of microbiota and strain-specific factors in CD and suggest further research into microbiota manipulation as a potential therapeutic strategy.